10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,078,051 | -31.2% | 50,377 | -6.9% | 0.01% | -30.0% |
| Q2 2023 | $3,020,274 | +9.6% | 54,088 | +9.5% | 0.01% | 0.0% |
| Q1 2023 | $2,756,919 | +19.7% | 49,416 | -21.8% | 0.01% | +11.1% |
| Q4 2022 | $2,303,773 | +27.9% | 63,221 | 0.0% | 0.01% | +28.6% |
| Q3 2022 | $1,801,000 | -29.3% | 63,221 | +12.2% | 0.01% | -30.0% |
| Q2 2022 | $2,549,000 | -32.7% | 56,330 | +13.1% | 0.01% | -16.7% |
| Q1 2022 | $3,790,000 | -45.4% | 49,823 | +6.9% | 0.01% | -40.0% |
| Q4 2021 | $6,942,000 | +5.5% | 46,601 | +3.1% | 0.02% | 0.0% |
| Q3 2021 | $6,582,000 | -25.2% | 45,210 | +0.6% | 0.02% | -31.0% |
| Q2 2021 | $8,801,000 | +22.6% | 44,942 | +13.3% | 0.03% | +16.0% |
| Q1 2021 | $7,180,000 | +166.9% | 39,666 | +108.8% | 0.02% | +150.0% |
| Q4 2020 | $2,690,000 | – | 19,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |